Showing results (621-630 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|December 14, 2006
Efficacy of botulinum toxin type a in the relief of Carpal tunnel syndrome: A preliminary experienceChing-Piao Tsai, Chih-Yang Liu, Kon-Ping Lin, et al.Clinical Drug Investigation|December 14, 2006
Treatment of stress urinary incontinence with non-animal stabilised hyaluronic acid/dextranomer (NASHA/Dx) gel : An analysis of utility and costGisela Kobelt, Aino Fianu-JonassonClinical Drug Investigation|December 14, 2006
Intravenous or sequential ciprofloxacin therapy in hospitalised patients with a broad spectrum of infections: a post-marketing surveillance studyH Koch, H Landen, K StauchClinical Drug Investigation|December 21, 2006
Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patientsJules L Dienstag, Lee-Jen Wei, Dong Xu, et al.Clinical Drug Investigation|December 21, 2006
Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndromeS Quaranta, M A Buscaglia, M G Meroni, et al.Clinical Drug Investigation|December 21, 2006
Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance studyHans-Christoph Diener, Stefan EversClinical Drug Investigation|December 14, 2006
Cost effectiveness of levocetirizine in chronic idiopathic urticaria : a pooled analysis of two randomised controlled trialsAlexander Kapp, Nadia DemarteauClinical Drug Investigation|December 14, 2006
Levetiracetam in idiopathic generalised epilepsy and porphyria cutanea tardaLeonilda Bilo, Roberta Meo, Maria Fulvia de LevaClinical Drug Investigation|December 14, 2006
Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitorsIbrahim Alabbadi, Grainne Crealey, Michael Scott, et al.Clinical Drug Investigation|August 21, 2007
Cost-effectiveness analysis of ziprasidone versus haloperidol in sequential intramuscular/oral treatment of exacerbation of schizophrenia: economic subanalysis of the ZIMO trialFernando Cañas, Víctor Pérez-Solá, Silvia Díaz, et al.Pageof 233